Search Results - "Food and Drug Administration"

Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration's Adverse Event Reporting System from 2016 to 2021 by Christine Learned, BA, Sara Alsukait, MBBS, Sandhya Deverapalli, MD, MBBS, Erika Elliott, MD, Katherine Moody, MD, Jeffrey Sobell, MD, Nellie Konnikov, MD, Melissa Ortega, PharmD, David Rosmarin, MD

Connect to this object online.

Evaluating cardiac disorders associated with triazole antifungal agents based on the US Food and Drug Administration Adverse Event reporting system database by Jinhua Chen, Shijun Xu, Weijiang Yu, Cuicui Sun, Wenzhou Zhang

Connect to this object online.

Bromocriptine mesylate: Food and Drug Administration approved new approach in therapy of non-insulin dependant diabetes mellitus with poor glycemic control by Yogendra Keche

Connect to this object online.

Evaluating drug withdrawal syndrome risks through food and drug administration adverse event reporting system: a comprehensive disproportionality analysis by Zheng Zhang, Qianzhi Yang, Minghao Chen, Wah Yang, Yuping Wang

Connect to this object online.

Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database by Yi Zheng, Xiaojing Guo, Chenxin Chen, Lijie Chi, Zhijian Guo, Jizhou Liang, Lianhui Wei, Xiao Chen, Xiaofei Ye, Jia He

Connect to this object online.

Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database by Jing Peng, Hui Wang, Zhen Liu, Zhen-Liang Xu, Mei-Xia Wang, Qi-Miao Chen, Ming-Li Wu, Xiao-Lei Ren, Qiu-Hua Liang, Fu-Peng Liu, Bo Ban

Connect to this object online.

Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study by Britney A. Stottlemyer, Michael C. McDermott, Mackenzie R. Minogue, Matthew P. Gray, Richard D. Boyce, Sandra L. Kane-Gill

Connect to this object online.

Erratum: Evaluating cardiac disorders associated with triazole antifungal agents based on the US food and drug administration adverse event reporting system database by Frontiers Production Office

Connect to this object online.

Analysis of the Association of Administration of various glucocorticoids with development of acute pancreatitis using US Food and Drug Administration adverse event reporting system (FAERS) by Daisuke Nango, Yukifumi Hirose, Makoto Goto, Hirotoshi Echizen

Connect to this object online.

Evidence of Accidental Dosing Errors with Immediate-Release Sodium Oxybate: Data from the US Food and Drug Administration Adverse Event Reporting System by Jennifer Gudeman, Danielle Burroughs

Connect to this object online.

Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis by Zhou, Zeyun, Hultgren, Kyle Emerson

Connect to this object online.

The use and safety risk of repurposed drugs for COVID-19 patients: lessons learned utilizing the Food and Drug Administration's Adverse Event Reporting System by Deemah S. Alsuhaibani, Heba H. Edrees, Thamir M Alshammari

Connect to this object online.

Evaluation of a natural language processing tool for extracting gender, weight, ethnicity, and race in the US food and drug administration adverse event reporting system by Vivian Dang, Eileen Wu, Cindy M. Kortepeter, Michael Phan, Rongmei Zhang, Yong Ma, Monica A. Muñoz

Connect to this object online.

Impact of the Food and Drug Administration enforcement policy on flavored e-cigarettes on the online popularity of disposable e-cigarettes: analyses of Google search query data by Ellen Boakye, Omar Dzaye, John Erhabor, Ngozi Osuji, Olufunmilayo Obisesan, Albert D. Osei, Aruni Bhatnagar, Rose Marie Robertson, Michael J. Blaha

Connect to this object online.

Cardiotoxicity in Biological Agent-Targeted Therapy for Rheumatoid Arthritis: ADR Signal Mining and Analysis of Food and Drug Administration Adverse Event Reporting System Database by Xiaoyan Tang, Xiaolin Xu, Ji Li, Bin Zhao

Connect to this object online.

Suspected adverse drug reactions of rivaroxaban reported in the United States food and drug administration adverse event reporting system database: a pharmacovigilance study by Jingying Wu, Jianru Wu, Biyu Tang, Xinru Wang, Fenfang Wei, Yi Zhang, Limin Li, Hongqiao Li, Bei Wang, Wenyu Wu, Xiang Hong

Connect to this object online.

Analysis of Secondary Leukemia and Myelodysplastic Syndrome After Chemotherapy for Solid Organ Tumors Using the Food and Drug Administration Adverse Event Reporting System (FAERS) by Takehiro Kawashiri, Daisuke Kobayashi, Mayako Uchida, Shiori Hiromoto, Masashi Inoue, Hajime Ikeda, Mizuki Inoue, Takao Shimazoe

Connect to this object online.

A real-world pharmacovigilance study of KRAS G12C mutation inhibitors based on the food and drug administration adverse event reporting system by Lisha Wu, Lisha Wu, Maosheng Xu, Xueqin Li, Dilinuer Aierken, Jinxiu Yu, Tao Qin, Tao Qin

Connect to this object online.

Anaphylaxis Associated With Allergen Specific Immunotherapy, Omalizumab, and Dupilumab: A Real World Study Based on the US Food and Drug Administration Adverse Event Reporting System by Sainan Bian, Sainan Bian, Sainan Bian, Pingping Zhang, Pingping Zhang, Lisha Li, Lisha Li, Lisha Li, Zixi Wang, Zixi Wang, Zixi Wang, Le Cui, Le Cui, Le Cui, Yingyang Xu, Yingyang Xu, Yingyang Xu, Kai Guan, Kai Guan, Kai Guan, Bin Zhao, Zhuanggui Chen, Zhuanggui Chen

Connect to this object online.

Parasitic infections related to anti-type 2 immunity monoclonal antibodies: a disproportionality analysis in the food and drug administration's adverse event reporting system (FAERS) by Victor Pera, Guy G. Brusselle, Guy G. Brusselle, Sebastian Riemann, Jan A. Kors, Erik M. Van Mulligen, Rowan Parry, Marcel de Wilde, Peter R. Rijnbeek, Katia M. C. Verhamme

Connect to this object online.